High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults

Lignende værker

• High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults
  af: GL Phillips, et al.
  Udgivet: (1991)
• Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected] [published erratum appears in Blood 1992 Jun 15;79(12):3397]
  af: Klingemann Hg, et al.
  Udgivet: (1991)
• Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]
  af: DE Reece, et al.
  Udgivet: (1994)
• Varying intensity of postremission therapy in acute myeloid leukemia
  af: PA Cassileth, et al.
  Udgivet: (1992)
• CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
  af: Lancet, Jeffrey E., et al.
  Udgivet: (2018)